Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amylyx Pharmaceuticals (AMLX) Exchange Rate Effect (2021 - 2025)

Amylyx Pharmaceuticals has reported Exchange Rate Effect over the past 5 years, most recently at $118000.0 for Q4 2025.

  • Quarterly results put Exchange Rate Effect at $118000.0 for Q4 2025, up 122.48% from a year ago — trailing twelve months through Dec 2025 was $1.1 million (up 345.21% YoY), and the annual figure for FY2025 was $1.1 million, up 345.21%.
  • Exchange Rate Effect for Q4 2025 was $118000.0 at Amylyx Pharmaceuticals, down from $151000.0 in the prior quarter.
  • Over the last five years, Exchange Rate Effect for AMLX hit a ceiling of $608000.0 in Q2 2025 and a floor of -$525000.0 in Q4 2024.
  • Median Exchange Rate Effect over the past 5 years was $5500.0 (2021), compared with a mean of $41222.2.
  • Peak annual rise in Exchange Rate Effect hit 5533.33% in 2022, while the deepest fall reached 18550.0% in 2022.
  • Amylyx Pharmaceuticals' Exchange Rate Effect stood at $9000.0 in 2021, then soared by 5533.33% to $507000.0 in 2022, then tumbled by 53.25% to $237000.0 in 2023, then crashed by 321.52% to -$525000.0 in 2024, then skyrocketed by 122.48% to $118000.0 in 2025.
  • The last three reported values for Exchange Rate Effect were $118000.0 (Q4 2025), $151000.0 (Q3 2025), and $608000.0 (Q2 2025) per Business Quant data.